labiotech.eu
Most recent 1 articles
Schizophrenia Treatments Could be Tested and Personalized Using Patients’...
“Mental disorders are the leading cause of disability worldwide, however neuropsychiatric drug discovery programmes by large pharma companies have shrunk by 70% in the past 10 years, and continue to decrease,” Santiago Lago, one of the researchers involved in the study, told me.
A team o…